Abstract. Bursts of actin polymerization in vivo involve the transient appearance of free barbed ends. To determine how rapidly barbed ends might appear and how long they might remain free in vivo, we studied the kinetics of capping protein, the major barbed end capper, binding to barbed ends in vitro. First, the off-rate constant for capping protein leaving a barbed end is slow, predicting a half-life for a capped barbed end of ~30 min. This half-life implies that cells cannot wait for capping protein to spontaneously dissociate from capped barbed ends in order to create free barbed ends. However, we find that phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol 4-monophosphate (PIP) cause rapid and efficient dissociation of capping protein from capped filaments. PIP2 is a strong candidate for a second messenger regulating actin polymerization; therefore, the ability of PIP2 to remove capping protein from barbed ends is a potential mechanism for stimulating actin polymerization in vivo. Second, the on-rate constant for capping protein binding to free barbed ends predicts that actin filaments could grow to the length of filaments observed in vivo during one lifetime. Third, capping protein [3-subunit isoforms did not differ in their actin binding properties, even in tests with different actin isoforms. A major hypothesis for why capping protein 13-subunit isoforms exist is thereby excluded. Fourth, the proposed capping protein regulators, Hsc70 and S100, had no effect on capping protein binding to actin in vitro.
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C
ONTROL of actin assembly is essential for cell locomotion and rapid changes in cell shape. One hypothesis for regulating the location and dynamics of actin polymerization in vivo is to alter the availability of free actin filament barbed ends near the plasma membrane. In vitro, the barbed end of an actin filament is the end favored for actin polymerization and, thus, is a likely site for rapid actin polymerization in cells. Upon stimulation of several types of cells, increased numbers of free barbed ends correlate with increased actin polymerization. The polymerization is sensitive to cytochalasin and, therefore, involves barbed ends (7, 24, 25, 46) .
Most actin filament barbed ends are not freely accessible in cells (25, 34) and are likely blocked from elongation by the barbed end binding protein, capping protein (18, 53) . Knowing the dynamics of capping protein binding to F-actin and the intracellular concentrations of capping protein and actin would enable us to predict the half-lives of free and capped barbed ends in cells and to predict how capping protein participates in regulating actin assembly. Therefore, we determined the kinetic rate constants for actin binding of capping protein from muscle (CP-131) and vertebrate nonmuscle tissues (CP-132). (The name "capping protein," given to the first member of this family of barbed end actin binding proteins [34a] , is used here to refer to the vertebrate homologue. To differentiate the vertebrate capping protein isoforms, we use the name CP-131, for capping protein containing the 131-subunit [CP-131 is also known as CapZ because of its location at Z-disks {11}], and CP-132, for capping protein containing the 132-subunit. ) We also investigated potential signals proposed to regulate the actin binding activities of capping protein. Regulated uncapping of actin filaments is an attractive mechanism for increasing the number of free barbed ends in response to extracellular signals. Capping protein is released from the actin cytoskeleton upon platelet activation (47) , consistent with uncapping. In addition, the maintenance of uncapped filament barbed ends at the rear of Listeria has been proposed as one mechanism for the actin assembly that drives movement of the bacterium (44) .
Polyphosphoinositides have been proposed to mediate actin assembly (37) ; in particular, uncapping of barbed ends by phosphatidylinositol 4,5-bisphosphate (PIP2) 1 has been proposed as a mechanism for increasing actin assembly in activated platelets (27) . Therefore, we tested the ability of phosphoinositides to promote dissociation of capping protein from F-actin. Hsc70 (21, 28) and S100 proteins (35, 36) also have been reported to interact with capping protein, but their effects on actin binding using purified components are not known. Therefore, we tested whether or not Hsc70 and S100 proteins affect the actin binding properties of capping protein.
Vertebrates have two isoforms of the capping protein 13 subunit. CP-[31 is the predominant capping protein of muscle and is found at Z-disks of sarcomeres (11) . CP-132 is the predominant isoform in nonmuscle tissues. CP-132 also is expressed in small amounts in muscle cells, where it is distributed at the cell periphery, but not at Z-disks (54) . The two 13 subunits arise from alternatively spliced mRNA transcripts and only differ in ~30 amino acids at their COOH termini. The different COOH-terminal amino acid sequences are presumed to be important because they are highly conserved among vertebrates. Since the COOH terminus of the 13 subunit is necessary for binding actin (33), we hypothesized that the isoforms differ in their actin binding properties. For example, binding of CP-[31 to F-actin may be highly stable in order to stabilize the actin filaments of the sarcomere. On the other hand, binding of CP-132 to F-actin may be dynamic to regulate the rapid polymerization of cortical actin filaments important for locomotion and changes in shape. A corollary to this hypothesis is that the actin-binding properties of capping protein [3 subunit isoforms may be differentially modulated by cellular factors such as PIP2, Hsc70, and S100 proteins.
An alternate hypothesis to account for the existence of two 13 subunit isoforms is that CP-[31 and CP-132 interact selectively with different isoforms of actin. The distributions of CP-[31 to sarcomeres and CP-132 to the cortex within single cardiomyocytes (54) parallel the distributions of sarcomeric (a-actin) and nonsarcomeric (13-and 3,-actins) actins (16, 31, 48) . Therefore, CP-131 may preferentially bind a-actin and CP-[32 may preferentially bind [?,3,-actin.
To test the hypotheses that (a) the actin binding properties of CP-131 and CP-132 are different or are differentially regulated, and (b) that CP-[31 and CP-132 interact differentially with actin isoforms, we purified capping protein from chicken kidney (CP-132), from chicken brain (CP- [32) , and from chicken pectoral muscle (CP-131) and compared their actin binding activities using actin from skeletal muscle (a-actin), from erythrocytes (13-actin), and from brain (133,-actin).
Materials and Methods

Proteins, Reagents, and Antibodies
Capping protein of chicken skeletal muscle (CP-[31) was purified as described (6) . ¢~-Actin from chicken skeletal muscle was purified as described (55) . Pyrene-labeled actin was prepared as described (13) . Nonmuscle actins were purified from bovine erythrocytes ([3-actin) and from chicken brain ([3~-actin) according to a method based on DNase I affinity chromatography (40) . Spectrin-F-actin seeds were prepared as described (10) . Bovine heat-shock cognate protein-70 (Hsc70) and monoclonal antiHsc70 were obtained from StressGen Biotechnologies (Victoria, BC, Canada). Cytochalasin D and S-100 proteins (S100A, S100B, and S100aa) were obtained from Sigma Chemical Co. (St. Louis, MO), PIPz was purchased from Sigma Chemical Co. (sodium salt) and from BoehringerMannheim Corp. (ammonium salt; Indianapolis, IN); both sources of PIPa had identical effects in the actin-binding assays. Phosphatidylethanolamine (PE), phosphatidylinositol 4-monophosphate (PIP), phosphatidylinositol (PI), and phosphatidic acid (PA) were obtained from Sigma Chemical Co. Phosphatidylinositol 3,4,5-trisphosphate (PIP3) was a generous gift from Dr. C.-S. Chen (University of Kentucky, Frankfort, KY) (22) . All lipids stock solutions were prepared by sonication at 1 mg/ml in H20 and stored at -70°C; aliquots were sonicated for 20 min in a water bath sonicator before use. mAbs 3F2 and 5B12 were prepared in this laboratory and were purified from ascites fluid using protein A-agarose. mAb 3F2 was elicited in mice by immunization with a fusion protein of glutathione-S-transferase (GST) and the unique 27 COOH-terminal amino acids of chicken capping protein [32 subunit, mAb 5B12 was elicited in mice by immunization with a fusion protein of GST and the chicken ~1 subunit, mAb 3F2 reacts with the [32 subunit, but not the [31 subunit of chicken capping protein (Fig. 1) ; mAb 5B12 reacts with c~l and ct2 subunits of chicken capping protein (Fig. 1 ) . mAb 1E5 is specific for chicken capping protein [31 subunit (33, 54) .
Electrophoresis and Immunoblotting
SDS electrophoresis was performed as described (42) . Two-dimensional (2-D) gels and immunoblots were performed as described (54); 2-D gels were stained using the Silver Stain Plus reagent (BioRad Labs, Hercules, CA) as described by the manufacturer. Dot blots used to assay column fractions were performed by applying 1-2 txl of the column fractions to a nitrocellulose filter. The filter was air-dried and reacted with antibodies as for immunoblots.
Purification of Capping Protein (CP-fl2) of Kidney and Brain
CP-[32 was purified from chicken kidney and from chicken brain using methods similar to the protocol for purification of CP-[31 from skeletal muscle (6) . Tissue was frozen in liquid N2 (Pel-Freez Biologicals, Rogers, AK) and stored at -70°C until use. Approximately 100 g of brain or kidney was homogenized per 1 liter of 0.6 M KI, 20 mM Na2SzO3, 5 mM 2-mercaptoethanol, 1 mM NAN3, and the protease inhibitors 0.1 mM PMSF, 0.1 IxM pepstatin A, 0.1 ixM leupeptin, and 0.1 mM benzamidine using a polytron. The homogenate was centrifuged at 25,400 g for 30 min, and the resulting supernatant was centrifuged at 100,000 g for 1 h. The supernatant was dialyzed and chromatographed on DEAE-cellulose (DE-53; Whatman, Maidstone, England) as described (6) . The capping protein fraction was subjected to (NH4)2SO4 fractionation and chromatographed on Sephacryl S-200 (6). Pooled fractions were dialyzed against buffer H (10 mM KH2PO4, pH 7.0, 50 mM KCI, 0.5 mM DTT, and 0.01% NAN3), and the dialysate was applied to a 2.5 x 12-cm column of Bio-Gel HT (BioRad Labs) equilibrated in buffer H. The column was washed with ~-,100 ml buffer H and eluted with a 600-ml linear gradient of KHzPO4 from 10-400 mM in buffer H. The CP-[32 was chromatographed on a MonoS column (6), dialyzed against buffer M (10 mM Tris-Cl, pH 8.0, 1 mM EDTA, 0.5 mM DTT, and 0.1 mM PMSF), and applied to a MonoQ column. The column was eluted with a linear gradient from 04).35 M KC! in buffer M; fractions were assayed by falling ball viscometry and immunoblots of SDS gels using mAbs 3F2 and 5B12.
The purity of CP-[32 and a comparison of the subunit compositions of capping protein of skeletal muscle and kidney are documented in silverstained, 2-D gels (Fig. 2) . CP-[31 from skeletal muscle contains the al-and a2-subunits in a molar ratio of ~l : l and the 131 subunit (including a modified form of the [31 subunit called 131 ') (6, 54) . CP-[32 from kidney has two c~ subunits, cd and a2 in a ratio of ~1:2, and the 132 subunit; CP-[32 from brain had an identical subunit composition. Immunoblots of identical gels probed with antibodies specific for c~ subunits (mAb 5B12), the 131 subunit (mAb 1E5), and the 132 subunit (mAb 3F2) confirmed the identification of these protein spots (data not shown).
A minor protein component migrating in the 2-D gel with a mobility in the SDS dimension like that of the a subunits but having a more basic isoelectric point was detected in the capping protein preparations from kidney and skeletal muscle (labeled c~3? in Fig. 2) ; this protein reacted on immunoblots probed with mAb 5B12 (data not shown). This minor component may be the chicken homologue of a protein of mouse testicular germ cells that was identified by cDNA cloning and is similar to capping protein a subunits (56) ; the predicted isoelectric point of the mouse protein (pl = 6.7) is consistent with that of the protein we tentatively designate the c~3 subunit on the 2-D gels.
Critical Concentration Measurements and Determination of Dissociation Constants (Kd)
The effect of capping protein on the steady-state actin filament concentra- Figure 2 . Silver-stained two-dimensional gels of CP-131 purified from chicken pectoral muscle (upper gel) and CP-[32 purified from chicken kidney (lower gel). T h e positions of the individual capping protein subunits were identified by reaction with t~-and [3-specific antibodies and from the predicted mobilities of the subunits (15) . The major difference in subunit composition between the capping protein isoforms is the 13 subunit: CP-[31 contains the 131 s u b u n i t ([31 and 131') and CP-132 contains the 132 subunit. Preparations of both capping protein isoforms contained a small a m o u n t of a putative, novel a subunit protein we tentatively label "c~3?" based on its reaction with m A b 5B12 (data not shown).
tion for skeletal muscle ~-actin and erythrocyte 13-actin were determined by incubation of 1 ~M c~-or [3-actin (each containing 10% pyrene-labeled ~-actin as a tracer for polymerization) in MKEI buffer (0.1 M KCL 2 mM MgCI2, 1 mM EGTA and 20 mM imidazole-HCl, pH 7.0) with varying concentrations of CP-[31 and CP-[32. Samples were incubated for 24 h at room temperature with gentle rocking and pyrene fluorescence was measured (13) . The Kd for capping protein binding to actin was determined from the amount of capping protein that changes the critical concentration by 50% as described (58) using elongation rate constants for ATPactin (50) .
Actin Polymerization Assays
Actin polymerization from spectrin-F-actin seeds was assayed using 1.5 IxM actin (5 or 10% pyrene labeled), 0.054--0.25 nM spectrin-F-actin seeds and varying concentrations of CP-[3I or CP-132 in MKEI buffer. Monomeric actin was diluted to 1.5 txM in MKEI buffer and preincubated for 160 s to allow exchange of Mg z+ for Ca 2+ on the actin. Spectrin-F-actin seeds and either CP-131 or CP-[32 were added to the cuvette and pyrene fluorescence (5) was monitored for up to 1,040 s. Assays were performed at 25°C.
Actin Uncapping Assay
The uncapping assay was a modification of the actin polymerization assay using 0.23 nM spectrin-F-actin seeds, 2 ~M actin (5% pyrene labeled) and varying concentrations of CP-[31 or CP-132. The buffer was 0.l MKEI (0.1 M KCI, 0.2 mM MgCl2, 0.1 mM EGTA, and 20 mM imidazole-HCl, pH 7.0), which was determined to be optimal for PIP2-mediated uncapping. The reaction was initiated by the addition of the spectrin-F-actin seeds and capping protein to monomeric actin in 0.1 MKEI. Phospholipids were added to the polymerization reaction at 340 s and the fluorescence was monitored for a total of 1,200 s. Assays were performed at 25°C. Assays were performed using Hsc70 and S-100b in place of phospholipids to test whether these proteins induced uncapping. In some experiments, actin filaments capped by CP-[31 were used in place of spectrin-F-actin seeds. The capped filaments were prepared by mixing 0.11 izM CP-[31 and 11 I~M c~-actin in 0.1 MKEI buffer overnight at room temperature. To test mixed micelles of PIP2 and PE, PIP2 and PE were mixed in molar ratios of 1:3 to l:100, sonicated in a bath sonicator for 15 min and added to uncapping assays so that the final concentration of phospholipid was 100 ~tM.
Determination of the Rate Constants for Capping F-actin
The rate constants for capping actin filaments were determined from data collected in actin polymerization assays using the kinetic parameter optimization programs, KINSIM (3) and FITSIM (61) . The kinetic mechanism used for the simulation was steps 1 and 2 of the mechanism shown below, where A is actin monomer, AN is the number of actin filaments and also equals the number of speetrin-F-actin seeds, C is capping protein, and PIP2 is itself.
ANC + PIP 2 7:2 ANCPIP 2 (4)
The concentration of spectrin-F-actin seeds was determined by fitting the experimental data obtained for seeded polymerization of a-actin alone using KINSIM and the on-rate and off-rate constants for muscle a-actin, 11.6 ~M-~s -I and 1.4 s -~, respectively (50) . The on-rate and offrate constants for [3-actin were determined using KINSIM and the critical concentration for [3-actin (determined experimentally to be 0.16 ~M); the on-rate and off-rate constants for nonmuscle actin were 10.0 p,M ~s ~ and 1.6 s ~, respectively. This mechanism assumes that there is no pointed end growth from the spectrin-F-actin seeds. To confirm this assumption, we determined that no actin polymerization was observed during ~1,000 s after addition of the seeds in the presence of 20 nM cytochalasin D.
For kinetic simulations of the action of PIPz on capped filaments, steps 1-5 of the mechanism shown above were used. The on-rate and off-rate constants assigned for step 1 were 11.6 IxM ts-~ and 1.4 s -t, respectively, and for step 2 were 3.6 IxM is-1 and 4.0 X 10 -4 S -1, respectively. Rate constants for steps 3-5 were varied over a wide range to obtain simulated progress curves using KINSIM, which were compared with the experimental data for actin polymerization in the presence of capping protein and PIP2.
Actin Depolymerization Assay
F-actin at 5 IxM (40-50% pyrene-labeled) was mixed with varying amounts of CP-[31 or CP-132, incubated 5 min at room temperature, and diluted 25-fold into G buffer (2 mM Tris-Cl, pH 8.0, 0.2 mM ATP, 0.1 mM dithiothreitol, 0.2 mM CaCI2, and 0.005% NAN3) at 25°C in a fluorometer cuvette with a stirring bar (5) . The decrease in pyrene fluorescence accompanying actin depolymerization was monitored for 300 s after dilution. To test the effects of PIPe, phosphatidylinositol 3,4,5-trisphosphate Hsc70, and S-100 proteins on capping activity, 50 nM CP-[31 or CP-132 was incubated for 5 min with varying concentrations of the test reagent before addition to F-actin. The effects of Hsc70 were measured in the presence of 5 mM ATP or 5 mM ADP and 5 mM MgCI2. The effects of S-100 proteins were measured in the presence and absence of CaCI; at 0.2-1 mM.
Actin Nucleation Assay
Monomeric actin at 5 txM (10% pyrene labeled) was incubated with CP-131 or CP-132 for 5 rain in G buffer. Fluorescence of pyrene-actin was monitored after the addition of 1/10 volume of 10× MKEI to the cuvette.
Analysis of the Interaction of CP and Hsc70
For gel filtration analysis, CP-132 was mixed in a final volume of 0.2 ml in buffer S (10 mM Tris-HCl, pH 8.0, 0.2 M KCI, 1 mM dithiothreitol, 0.01% NaN 3, 0.5 mM EDTA, 5 mM ADP, and 5 mM MgCI2) with Hsc70 (molar ratio Hsc70:CP-132 of 2:1). The mixture was applied to a Superose 12 HR column (1 x 30 cm) equilibrated in buffer S. Fractions were assayed for capping protein and Hsc70 by Western blotting using mAb 5B12, mAb 3F2, and anti-Hsc70. Control runs were of Hsc70 alone and CP-132 alone. For immunoprecipitation analysis, CP-131 or CP-132 was mixed in a molar ratio of 3:1 (Hsc70:CP) with Hsc70 in a buffer containing 10 mM Tris-HCl, pH 7.4, 0.15 M NaCI, 0.1% Triton X-100, and 0.1 mg/ml bovine serum albumin. A final concentration of either 5 mM ATP and 5 mM MgCI2 or 5 mM ADP and 5 mM MgC12 was added to each sample. The mixtures were incubated for 1 h on ice; 10 Ixg of mAb 5B12, mAb 3F2, mAb 1E5, mouse IgG, or monoclonal anti-Hsc70 was added and incubated for 2 h. Immune complexes were isolated using BioMag goat anti-mouse lgG (PerSeptive Diagnostics, Cambridge, MA), washed eight times in 10 mM Tris-HC1, pH 7.4, 0.45 M NaC1, 1% Triton X-100 and twice in 10 mM Tris-HCl, pH 7.4, 0.15 M NaCI, 0.1% Triton X-100. The immune complexes were solubilized in SDS sample buffer and analyzed on Western blots probed with a mixture of mAb 5B12, mAb 3F2, mAb l E5, and anti-Hsc70.
Falling Ball Viscometry Assay
Falling ball viscometry assays were performed at room temperature as described (12) .
Results
Kinetic Rate Constants
The rate constants for binding of CP-131 and CP-132 to muscle a-actin, erythrocyte 13-actin, and brain 13"y-actin were determined using kinetic simulations of the time course of actin polymerization in the presence of varying concentrations of CP-151 and CP-132 (Fig. 3) The on-rate constants (k+) and the off-rate constants (k_) for CP-~31 and CP-132 (Table I) were similar to each other and to those determined for capping activity in supernatant fractions from neutrophils (18) . The on-rate constant for bind- ing ct-actin was slightly higher for CP-~2 (mean value derived from three determinations = 5.7 ixM-Is -I) than for CP-131 (mean value derived from three determinations = 3.5 /xM-ls-l). The off-rate constants for dissociation of capping protein from a barbed end were low (mean value derived from six determinations --4 × 10 -4 S-I). These rate constants predict that the half-life of a capped barbed end in cells is long (~28 rain), while the half-life for a free barbed end is short (~0.2 s); the implications of these halflives for control of actin polymerization by capping protein will be considered below (see Discussion). We also determined the dissociation constant (Kd) for binding CP-131 and CP-132 to muscle and nonmuscle actins by measuring the ability of each isoform to alter the critical concentration for actin polymerization (Fig. 4) . The Kas for actin binding (Table I) Fig. 4 using the point where the amount of F-actin changed by 50% as described in Materials and Methods. The error in this estimate was determined by estimating the error in the individual data points for each curve and calculation of the upper and rower limits for the Kd. :!These on-rate and off-rate constants were determined using the simulation program FITSIM; each value is the best fit obtained using 4-5 experimental data sets. The errors are the errors calculated by the algorithm for each independent analysis. The determinations using ot-actin were from three independent experiments; the rate constants with i3-actin and 13v-actin were each determined in one experiment. .~This off-rate was calculated from the Ku value indicated in column 3 of lhis table and the on-rate constant (column 4 of this table) determined using FITSIM. The formula is Kj = k_ i/k+ 1.
nM, and there was no difference in the Kas for binding of CP-131 and CP-132 to different actin isoforms. Our values for the Kd are consistent with the previously published Kd for CP-131 binding to c~-actin, which was reported to have an upper limit of 0.5-1 nM (6, 9) and with a Kd of 0.07 nM measured for binding human capping protein prepared by in vitro translation to ot-actin (2) . Because the determination of the off-rate constant from kinetic simulations is not as precise as the determination of the on-rate constant, we also calculated the off-rate constants from the on-rate constants and the KdS (Kd = k_/k+).
The values for these calculated off-rate constants (mean value from four determinations = 4 × 10 -4 s -1) are consistent with those obtained using kinetic simulations (Table I) . 
Comparison of the Actin Binding Properties of CP-fll and CP-fl2
The rate constants for CP-131 and CP-132 binding to actin were similar, even in assays with different actin isoforms.
To verify these results, we performed three additional assays that test properties different from those tested in the preceding experiments. First, CP-131 and CP-[32 were identical in their concentration dependence for inhibiting depolymerization of F-actin upon dilution (Fig. 5) . Second, both CP-131 and CP-I32 promoted nucleation of actin polymerization (Fig. 6) ; CP-131 nucleated actin polymerization slightly better than CP-132. Third, CP-[31 and CP-[32 had identical effects on the low-shear viscosity of F-actin (data not shown). The results from these assays confirm that the different structures of the 13 subunit isoforms neither confer a difference in the steady-state equilibrium binding to F-actin nor impart selective binding of CP-131 and CP-132 to different actin isoforms. The reason for the evolution and conservation of different COOH-terminal 13 subunit peptides in vertebrates remains unknown. The isoforms are targeted to different locations in the cell (54) . At those locations, the isoforms presumably possess some differentiation of function that justifies their targeting.
Regulation of Capping Protein
Regulation of capping activity is one mechanism to alter the availability of free barbed ends in cells. Three potential regulators of capping protein activity have been described based on their interactions with capping protein in vitro: anionic phospholipids, especially PIPe (30), heat shock cognate protein 70 (Hsc70) (20, 28) and $100 proteins (35) .
Uncapping Actin Filaments by Anionic Phospholipids
PIPe rapidly and efficiently promoted the dissociation of capping protein from actin filaments (Fig. 7 A) . Thus, PIP2 could be the signaI for uncapping barbed ends during actin remodelling in vivo. A typical uncapping assay using CP-131 and ct-actin is shown in Fig. 7 A; similar results were ob- tained using CP-132 and 13~-actin (data not shown). In this assay designed specifically to look at uncapping, PIP 2 at 36 IxM was added to a polymerization reaction containing capping protein at a time when most of the actin filaments were capped (arrow at 340 s for curve 3 in Fig. 7 A) . The rate of actin polymerization increased dramatically upon addition of the PIP2 (compare curves 2 and 3 in Fig. 7 A) , approaching the maximal rate of actin polymerization in the absence of capping protein (compare curves 1 and 3 in Fig. 7 A) . Cytochalasin D at 20 nM inhibited the increased rate of polymerization induced by PIP2 (curve 4 in Fig. 7 A) , indicating that free barbed ends had been created. PIP2 had no effect on the rate of polymerization of actin alone (data not shown), thus, PIP2 did not alter actin monomer interactions and did not sever filaments. Assays using capping protein-capped F-actin seeds in place of spectrin-Factin seeds gave similar results (data not shown).
Concentrations of PIP2 > ~40 ixM did not further increase the rate of polymerization. The half maximal effect was at ,'-~20 p~M PIP e (Fig. 7 B) . PIP 2 was equally effective in uncapping when present as mixed lipid vesicles with phosphatidylethanolamine (molar ratios of PIPz/PE of 1:2 and 1:9, data not shown). PIP also uncapped actin filaments but was less efficient than PIP 2 (Fig. 7B) . PI, PA, and, surprisingly, PIP3 had little or no uncapping activity (Fig. 7 B) . PIP3 has been proposed to control transient actin polymerization (43) since changes in the levels of PIP3 in platelets (41) and neutrophils (19) parallel the time course of actin polymerization and subsequent depolymerization in stimulated cells. We report the first description of the effect of PIP3 on the activity of an actin binding protein and find that PIP3 did not uncap filaments at all and was less potent than PIP2 in inhibiting capping activity (see below). Thus, the different structural features of polyphosphoinositides, not merely their anionic character, determine how they interact with capping protein.
The uncapping activity of PIP 2 depended critically on the concentration of Mg2+; 0.2 mM MgC12 supported high activity. At 2 mM MgC12, PIP2 induced a far smaller increase in the rate of actin polymerization in the uncapping assay (data not shown). This slight effect was similar to that seen previously by Heiss et al., using 2 mM MgCl2 and a different experimental design (30) . The dependence of the PIPe-induced actin polymerization on [Mg e+] may be due to aggregation of PIP2 by divalent cations (38) . The free [Mg e÷] in cells is ~0.5 mM but is heterogeneously distributed. In peripheral regions near the plasma membrane where PIP2-mediated signaling should occur, the free [Mg e+] is significantly lower (17, 52) . Thus, the low [Mg 2÷] necessary for optimal PIP2-mediated uncapping is likely to exist in vivo.
Inhibition of Capping Activity by Phosphoinositides
The capping activity of CP-132 was inhibited in a concentration-dependent manner by PIP2 (Fig. 8 B) , as previously observed for CP-131 (Fig. 8 A) (30) . PIP 3 also inhibited capping protein but concentrations ~10-fold higher than those required for inhibition by PIP2, were required for inhibition of capping activity by PIP3 (Fig. 8 C) .
Effects of Hsc 70 on Capping Protein Activity
Regulation of Dictyostelium capping protein by Hsc70 was suggested by the existence of a stable complex between Hsc70 and capping protein in whole cell extracts (21, 28) and by an Hsc70-induced increase in capping activity of mixtures of bacterially expressed capping protein c~ and [3 subunits (28) . The availability of purified capping protein and Hsc70 allowed us to test whether or not Hsc70 directly alters capping protein's actin binding activity. Hsc70 from bovine brain in the presence of either 5 mM ATP or 5 mM ADP had no effect on the capping activity of CP-[31 or CP-132 as measured in actin depolymerization assays (Fig. 9) . Hsc70 also did not promote uncapping (data not shown).
We found no evidence for formation of a stable complex (21) . The mixture was subjected to gel filtration analysis and to immunoprecipitation using antibodies to either capping protein or Hsc70 (28) .
Results from both sets of experiments indicated that Hsc70 did not associate with capping protein.
Taken together, our results indicate that Hsc70 does not bind to or influence the activity of capping protein, which is in contrast with conclusions of previous studies (28) .
Recent experiments on purified Dictyostelium capping Time (sec) Figure 9 . Hsc70 has no effect on the actin capping activity of CP-f31 (upper) and CP-~2 (lower) in actin depolymerization assays.
Hsc70, in the presence of 5 mM Mg-ADP, was incubated at varying molar ratios with CP-131 and CP-[32 for 5 min at room temperature before addition to 5 ~M F-oL-actin. The mixture was diluted into G buffer, and the change in pyrene fluorescence was monitored with time after dilution. Experiments performed in the presence of 5 mM Mg-ATP gave identical results (data not shown).
protein also conclude that the isoform of Hsc70 that copurifles with capping protein does not regulate capping protein (21) . In the previous studies, which used whole cell extracts, Hsc70 may have acted as a chaperone to promote the folding of capping protein. Alternative explanations for the difference between our results and the earlier studies include that bovine Hsc70 may not interact with chicken capping protein and that a specific isoform of Hsc70, not the one tested here, interacts with capping protein.
Effects of S I O0 Proteins on Capping Protein Activity
$100 proteins have been proposed to regulate actin filament assembly in vivo via a calcium-dependent interaction with capping protein (35, 36) . We tested whether or not $100 proteins alter the interaction of CP-[31 with c~-actin in the presence and absence of CaCl2. Three types of experiments were performed: falling ball viscometry assays, actin depolymerization assays, and assays for uncapping of capped actin filaments. We find that S100 protein binding to capping protein does not alter capping protein's interaction with actin (data not shown); therefore, capping protein can simultaneously bind actin and $100 protein. Capping protein may serve to position $100 protein at Z-disks, the location of both capping protein (11) and S100a0 (23) in muscle. The importance of locating $100 protein in the sarcomere is underscored by the recent finding that S100A12 activated in a CaZ+-dependent manner the kinase domain of twitchin, which may be important for organizing muscle structure and regulating contraction (29) .
Discussion
Implications of Kinetics of Capping Protein
Knowing the rate constants for the interaction of capping protein with actin filaments in vitro is necessary to understand how capping protein may regulate the dynamics of actin assembly in vivo. Kinetic rate constants allow one to predict the half-lives for free and capped actin filament barbed ends and to predict the amount of actin polymerized during the time a barbed end is free. The rate of uncapping can also be compared with the rate of creation of free barbed ends in cells stimulated by agents that induce rapid changes in the actin cytoskeleton.
Implications of the On-rate Constant
The on-rate constant of 3.0 ~M-Is -1, together with a cellular concentration of capping protein from 0.2 to 2 I~M (14, 18, 34, 47) , predicts a half-life for a free barbed end in vivo of 0.1-1 s. Actin polymerization from free barbed ends depends on the concentration of available actin subunits, which includes the pools of profilin-actin and free G-actin monomer (49, 51) . At an upper limit for the actin subunit pool in vivo of ~100 p~M (8), a free barbed end could grow from 0.3 to 3 ~zm during 0.1 to 1 s. Thus, actin filaments with free barbed ends could elongate to lengths observed for actin filaments in vivo (0.5-0.6 ~m in macrophages [26] ; 0.18-2.1 ~m in neutrophils [7] ; ~0.3 ~m in Listeria tails [57] ) before being capped.
Implications of the Off-rate Constant
The off-rate constant of 4 x 10 -4 s -1 for dissociation of capping protein from F-actin predicts a half-life for a capped barbed end of ~28 min. This half-life is much longer than the time observed for the increase in number of barbed ends and in F-actin in cells responding to stimuli. For example, within 90 s after neutrophils encountered chemoattractant, the amount of F-actin and the total number of actin filaments more than doubled (7) . Also, within 30 s after stimulation of platelets with thrombin, the number of free barbed ends increased from ~50 to ~500 per platelet (25, 27) . This large discrepancy between the rapid rate for actin remodelling in vivo and the slow rate for dissociation of capping protein from barbed ends led us to search for factors that accelerate uncapping of barbed ends. Regulators that cause uncapping also may account for the discrepancy between the apparent Ka of ~100 nM for Dictyostelium capping protein in whole cell extracts (34) and the K d of ~1 nM for purified Dictyostelium capping protein (21) .
Uncapping Actin Filaments by Phosphoinositides
Our tests of several possible regulators of capping protein indicate that the polyphosphoinositides, PIP2 and, to a lesser extent, PIP, induce the dissociation of capping protein from barbed ends. It is likely that PIP2 binds directly to capping protein and increases its rate constant for dissociation from F-actin. Kinetic simulations based on such a model predict the observed changes in actin polymerization well (see description of simulations in Materials and Methods). In contrast, simulations of a model in which PIP2 sequesters free capping protein after it dissociates from barbed ends at the usual slow rate do not fit the experimental data.
Is the PIP2-induced actin polymerization from capped filaments observed in vitro sufficient to account for increased actin polymerization in stimulated cells? In platelets, ~500 new free barbed ends were created from ~2,000 capped filaments by 30-60 s after stimulation with thrombin (27) . At conditions for maximal uncapping in vitro, PIP2 decreased the half-life for a capped barbed end from ~28 min to ~46 s. We calculate from a tile of 46 s that 500 free barbed ends could be created in ~19 s. Thus, the rate of PIP2-induced uncapping observed in vitro is sufficient to account for the number of free barbed ends that appear in stimulated platelets.
Signal transduction pathways in which phosphoinositides function require that the levels of phosphoinositides change in response to the stimulus. However, the total mass of PIP2 decreases, rather than increases following stimulation of platelets (59) . On the other hand, turnover of PIP2 is increased in platelets upon stimulation (1), raising the possibility that local changes in the PIP 2 concentration occur during signaling. The identification in some cells of specialized membrane domains enriched in PIP2, glycosphingolipids, and a polyphosphoinositide phosphatase (4, 32) supports the idea that the PIP2 concentration may vary spatially.
Model for Actin Assembly In Vivo
We propose a mechanism for remodeling the actin cytoskeleton in stimulated cells that accounts for the increases in the number of actin filaments, number of free barbed ends, and amount of F-actin. Our model is based on three processes: uncapping of barbed ends by the action of PIP2, polymerization at the free barbed ends, and severing the long actin filaments (Fig. 10) . First, PIP2 in the plasma membrane (Fig. 10, green) uncaps actin filaments and generates free barbed ends near the membrane. Polymerization at free barbed ends lengthens the filaments and extends lamellae and filopodia. PIP2 also inhibits capping of free barbed ends, thereby prolonging filament elongation. Next, the elongated filaments break, creating new filaments with free pointed and barbed ends. Finally, when the local PIP2 level decreases, capping protein caps the free barbed ends to stop polymerization.
We demonstrate here that PIP2 does uncap actin filament barbed ends. PIP 2 is part of the signaling pathway that induces actin polymerization in permeabilized plate- lets (27) . Furthermore, capping protein is released from platelet cytoskeletons upon stimulation by thrombin (47) . These data are consistent with the first steps of our model where signals mediated by PIPe induce actin remodeling by uncapping barbed ends.
One aspect of actin remodeling in vivo that cannot be explained solely by uncapping is an increase in the number of actin filaments. During platelet activation, the total number of filaments increases from 2,000 to 2,500 per cell (27) . More dramatic are the findings in stimulated neutrophils, where the number of actin filaments increases from 1.7 x 105 to 4 × 105 per cell without a change in actin filament length (7) . Clearly, additional processes, such as severing or de novo nucleation, two processes that create new filaments, are required to explain these data.
We favor a mechanism where long actin filaments are fragmented to create new filaments. One possible mechanism for breaking filaments is via mechanical forces exerted on them by myosins or other factors. Alternatively, actin filament severing proteins of the ADF/cofilin or gelsolin families may serve this role. ADF/cofilins are ubiquitous, present at high concentrations in vivo, and can be regulated by phosphorylation and polyphosphoinositides (for review see [45] ). The contribution to severing by gelsolin may be minor since platelets lacking gelsolin assemble actin normally in response to thrombin (60). The gelsolin analogue adseverin/scinderin is another candidate (for review see [53] ).
Nucleation of actin filaments de novo from actin monomers is an alternative mechanism to create new filaments. Capping protein nucleates actin polymerization in vitro at a rapid rate (6). However, filaments nucleated by capping protein are capped at their barbed ends, thus, free barbed ends would not increase unless the new filaments were either uncapped or severed. In addition, PIPe inhibits the nucleation activity of capping protein (30); thus, increased PIPe would inhibit, rather than promote, actin polymerization nucleated by capping protein.
